# 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

> **NCT01991977** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 91 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **PROCEDURE:** Diffusion Weighted Imaging
- **DRUG:** Fluorine F 18 Fluorodopa
- **RADIATION:** Intensity-Modulated Radiation Therapy
- **PROCEDURE:** Perfusion Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT01991977
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2019-07-01
- **Final completion:** 2024-07-15
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01991977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01991977, "18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01991977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*